Molecular Genetics of Coagulation Factor VIII Gene and Hemophilia A

Stylianos E Antonarakis

doi:10.1055/s-0038-1642697

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1995; 74(01): 322-328
DOI: 10.1055/s-0038-1642697

Symposium

Molecular Basis of Haemophilias

Schattauer GmbH Stuttgart

Molecular Genetics of Coagulation Factor VIII Gene and Hemophilia A

Stylianos E Antonarakis

“Genes ‘R’ Us” Laboratory of Human Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School & Division of Medical Genetics, Cantonal Hospital, Geneva, Switzerland

› Author Affiliations

Abstract

PDF Download

PDF (575 kb)

References

References
1 Hoyer LW, Hemophilia A. N Eng J Med. 1994; 330: 38-47
2 Rizza CR, Spooner RJ D. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: Report on behalf of the Directors of Haemophilia Centres in the United Kingdom. Brit Med J 1983; 286: 929-933
3 Hoyer LW. Molecular pathology and immunology of factor VIII. HumPathol 1987; 18: 153-161
4 Lazarchick J, Hoyer LW. Immunoradiometric measurement of the factor VIII procoagulant antigen. J Clin Invest 1976; 62: 1048-1052
5 Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DE, Vehar GA, Capon DJ, Lawn RM. Characterization of the human factor VIII gene. Nature 1984; 312: 326-330
6 Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DL, Hollingshead P, Wion KL, Delwart E, Tuddenham EG D, Vehar GA, Lawn RM. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-337
7 Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Amphlett GW, Foster WB, Coe ML, Knutson GJ, Fass DN, Hewick RM. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-347
8 Poustka A, Detrich A, Langenstein G, Toniolo D, Warren ST, Lehrach H. Physical map of Xq27-Xqter: localizing the region of the fragile X mutation. Proc Natl Acad Sci USA 1991; 88: 8302-8306
9 Freije D, Schlessinger D. A 1.6 mb contig of yeast artificial chromosomes around the human factor VIII gene reveals three regions homologous to probes for the DXS115 locus and two for the DXYS64 locus. Am J Hum Genet 1992; 51: 66-80
10 Migeon BR, McGinnis MJ, Antonarakis SE, Axelman J, Stasiowski B, Youssoufian H, Kearns WG, Chung A, Pearson PL, Kazazian Jr HH, Muneer RS. Severe hemophilia A in a female by cryptic translocation: order and orientation of factor VIII within Xq28. Genomics 1993; 16: 20-25
11 Levinson B, Kenwrick S, Lakich D, Hammonds G, Gitschier J. A transcribed gene in an intron of the human factor VIII gene. Genomics 1990; 7: 1-11
12 Levinson B, Beimingham JR, Metzenberg A, Kenwrick S, Chapman V, Gitschier J. Sequence of the human factor VUI-associated gene is conserved in mouse. Genomics 1992; 13: 862-865
13 Levinson B, Kenwrick S, Gamel P, Fisher K, Gitschier J. Evidence for a third transcript from the human factor VIII gene. Genomics 1992; 14: 585-589
14 Wion KL, Kelly D, Summerfield JA, Tuddenham EG D, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-729
15 Zelechowska MG, van Mourik JA, Brodniewicz-Proba T. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 1985; 317: 729-731
16 Vehar GA, Keyt B, Eaton D, Rodriguez H, O’Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EG D, Lawn RM, Capon DJ. Stmcture of human factor VIII. Nature 1984; 312: 337-342
17 Koschinsky ML, Funk WD, van Ooar BA, MacGillivray RT A. Complete cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci USA 1986; 83: 5086-5090
18 Kane WH, Davie EW. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Aca Sci USA 1986; 83: 800-6804
19 Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V , a blood coagulation factor with four types of repeats. Biochemistry 1987; 26: 6508-6514
20 Stubbs JD, Lekutis C, Singer KL, Bui A, Yuzuki D, Srinivasan U, Pany G. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like sequences. Proc Natl Acad Sci USA 1990; 87: 8417-8421
21 Elder B, Lakich D, Gitschier J. Sequence of the murine Factor VIII cDNA. Genomics 1993; 16: 374-379
22 Kaufman RJ, Antonarakis SE. Stmcture, biology and genetics of factor VIII. In: Hoffman R. eds. et al Hematology; Basic principles and practice. 2nd ed Churchill Livingstone; New York: 1994: 1633-1684
23 Tuddenham EG D, Schwaab R, Seehafer J, Millar DS, Gitschier J, Higuchi M, Bidichandani S, Connor JM, Hoyer LW, Yoshioka A, Peake IR, Olek K, Kazazian HH, Lavergne JM, Giannelli F, Antonarakis SE, Cooper DN. Haemophilia A: Database of nucleotide substitutions,deletions,insertions and rearrangements of the factor VIII gene-second edition. Nucl Acids Res 1994; 22: 3511-3533
24 Antonarakis SE, Kazazian HH, Tuddenham EG D. Molecular etiology of Factor VIII. Deficiency in hemophilia A. Hum Mut 1995; 5: 1-22
25 Higuchi M, Antonarakis SE, Kasch L, Oldenburg J, Economou-Petersen E, Olek K, Inaba H, Kazazian HH. Towards a complete characterization of mild to moderate hemophilia A: detection of the molecular defect in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 1991; 88: 8307-8311
26 Higuchi M, Kazazian HH, Kasch L, Warren TC, McGinniss MJ, Phillips JA, Kasper C, Janco R, Antonarakis SE. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding region and splice junctions of the factor VIII gene. Proc Natl Acad Sci USA 1991; 88: 7405-7409
27 Naylor JA, Green PM, Rizza CR, Gianelli F. Analysis of factor VIII mRNA reveals defects in every one of 28 hemophilia A patients. Hum Mol Genet 1993; 2: 11-17
28 Lakich D, Kazazian HH, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene as a common cause of severe hemophilia A. Nature Genet 1993; 5: 236-241
29 Naylor JA, Green PM, Rizza CR, Gianelli F. Factor VIII gene explains all cases of hemophilia A. Lancet 1992; 340: 1066-1067
30 Naylor JA, Brinke A, Hassock S, Green PM, Giannelli F. Characteristic mRNA abnormality found in half the patients with severe hemophilia A is due to large DNA inversions. Hum Mol Genet 1993; 2: 1773-1778
31 Rossiter JP, Young M, Kimberland ML, Hutter P, Ketterling RP, Gitschier J, Horst J, Morris MA, Schaid DJ, deMoerloose P, Sommer SS, Kazazian HH, Antonarakis SE. Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum Mol Genet 1994; 7: 1035-1039
32 Antonarakis SE. 65 co-authors Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Submitted. 1995
33 Antonarakis SE, Kazazian Jr HH. The molecular basis of Hemophilia A in man. Trends Genet 1988; 4: 233-237
34 Youssoufian H, Antonarakis SE, Aronis S, Triftis G, Phillips DG, Kazazian Jr HH. Characterization of five partial deletions of the factor VIII gene. Proc Natl Acad Sci USA 1987; 84: 3772-3776
35 Lavergne JM, Bahnak BR, Vidaud M, Laurian Y, Meyer D. A directed search for mutations in hemophilia A using restriction enzyme analysis and DGGE. A study of seven exons in the factor VIII gene of 170 cases. Nouv Rev Fr Hematol 1992; 34: 85-91
36 Woods-Samuels P, Kazazian Jr HH, Antonarakis SE. Nonhomologous recombination in the human genome: Deletions in the human factor VIII gene. Genomics 1991; 10: 94-101
37 Kazazian Jr HH, Wong C, Youssoufian HG, Scott AF, Phillips D, Antonarakis SE. A novel mechanism of mutation in man: hemophilia A due to de novo insertion of LI sequences. Nature 1988; 332: 164-166
38 Fanning TG, Singer MF. LINE-1: a mammalian transposable element. Biochem Biophys Acta 1987; 910: 203-212
39 Kazazian Jr HH, Scott AF. “Copy and paste” transposable elements in the human genome. J Clin Invest 1993; 91: 1859-1860
40 Dombroski BA, Mathias SL, Nanthakumar E, Scott AF, Kazazian Jr HH. Isolation of a human transposable element. Science 1991; 254: 1808-1910
41 Mathias SL, Scott AF, Kazazian Jr HH, Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991; 254: 1808-1810
42 Woods-Samuels P, Wong C, Mathias SL, Scott AF, Kazazian Jr HH, Antonarakis SE. Characterization of a non-deleterious LI insertion in an intron of the human factor VIII gene and evidence for open reading frames in functional LI elements. Genomics 1989; 4: 290-296
43 Gitschier J. Maternal duplication associated with gene deletion in sporadic hemophilia. Am J Hum Genet 1988; 43: 274-279
44 Murru S, Casula L, Pecorara M, Mori P, Cao A, Pirastu M. Illegitimate recombination produced a duplication within the factor VIII gene in a patient with mild hemophilia A. Genomics 1990; 7: 115-118
45 Youssoufian H, Kazazian Jr HH, Phillips DG, Aronis S, Tsiftis G, Brown VA, Antonarakis SE. Recurrent mutations in haemophilia A give evidence for CpG mutations hotspots. Nature 1986; 324: 380-382
46 Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 74: 151-155
47 Diamond C, Kogan S, Levinson B, Gitschier J. Aminoacid substitutions in conserved domains of factor VIII and related proteins: study of patients with mild to moderately severe hemophilia A. Hum Mut 1992; 1: 248-257
48 Youssoufian H, Antonarakis SE, Bell W, Griffin AM, Kazazian Jr HH. Nonsense and missense mutation in hemophilia A: estimate of the relative mutation rate at CpG dinucleotides. Am J Hum Genet 1988; 42: 718-725
49 Dietz HC, Valle D, Francomano CA, Kendzior Jr RJ, Pyeritz RE, Cutting GR. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 1993; 259: 680-682
50 Gitschier J, Kogan S, Levinson B, Tuddenham EG D. Mutations of factor VIII cleavage sites in hemophilia A. Blood 1988; 72: 1022-1028
51 Arai M, Inaba H, Higuchi M, Antonarakis SE, Kazazian HH, Fujimaki M, Hoyer LW. Detection of a mutation altering a thrombin cleavage site (arginine-372-histidine). Proc Natl Acad Sci USA 1989; 86: 4277-4281
52 O’Brien D, Pattinson JK, Tuddenham EG D. Purification and characterization of factor VIII 3372-cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A. Blood 1990; 75: 1664-1672
53 Johnson DJ D, Pemberton S, Acquila M, Mori PG, Tuddenham EG D, O’Brien DP. Factor VIII S373L: mutation at a PI site confers thrombin cleavage resistance, causing mild haemophilia A. Thromb & Hemost 1994; 71: 428-433
54 O’Brien DP, Tuddenham EG D. Purification and characterization of factor VIII 1689Cys: A non-functional cofactor occurring in a patient with severe haemophilia A. Blood 1989; 73: 2117-2122
55 Arai M, Higuchi M, Antonarakis SE, Kazazian HH, Phillips JA, Janco RL, Hoyer LW. Characterization of a thrombin cleavage site mutation (arg 1689 to cys) in the factor VIII gene of two unrelated patients with cross-reacting material positive hemophilia A. Blood 1990; 75: 384-389
56 Aly AM, Higuchi M, Kasper CK, Kazazian Jr HH, Antonarakis SE, Hoyer LW. Hemophilia A due to mutations that create new N-glycosylation sites. Proc Natl Acad Sci USA 1992; 89: 4933-4937
57 Higuchi M, Wong C, Kochhan L, Olek K, Aronis S, Kasper CK, Kazazian HH, Antonarakis SE. Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNA. Genomics 1990; 6: 65-71
58 Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP. et al Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1991; 266: 17572-17576
59 McGinniss MJ, Kazazian Jr HH, Hoyer LW, Bi L, Inaba H, Antonarakis SE. Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A. Genomics 1993; 15: 392-398
60 Sultan Y. Prevalence of inhibitors in a population of 3435 hemophilia patients in France. Thromb Haemost 1992; 67: 600-602
61 Fulcher CA, de Graff S, Mahoney S, Zimmerman TS. FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting. Blood 69: 1475-1480
62 Scandella D, Mattingly M, de Graaf S, Fulcher CA. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization. Blood 1990; 74: 1618-1626
63 Millar DS, Steinbrecher RA, Wieland K, Grundy CB, Martinowich U, Krawszak M, Zoll B, Whitmore D, Stephenson J, Mibashn RS, Kakkar VV, Cooper DN. The molecular genetic analysis of hemophilia A; characterization of six partial deletions of factor VIII gene. Hum Genet 1990; 86: 219-227
64 Peake IR, Lilli crap DP, Boulyjenkov V, Briet E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM, Nicolaides K, Tuddenham E GD. Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coagulation and Fibrinolysis 1990; 4: 313-344
65 Antonarakis SE, Kazazian Jr HH. Hemophilias In: Brock DJ H, Rodeck CH, Ferguson-Smith MA. eds. “Prenatal diagnosis and Screening”. Churchill Livingstone; Edinburgh: 1992: 477-481
66 Bi L, Lawler AM, Antonarakis SE, High KA, Gerhart JD, Kazazian Jr HH. Targeted disruption of the mouse factor VIII gene: a model for hemophilia A. Submitted. 1995